Rogerio Lobo

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi request reprint The rationale for low-dose hormonal therapy
    Rogerio A Lobo
    Columbia University s College of Physicians and Surgeons, 622 West 168 Street, 16th Floor, New York, NY 10032, USA
    Endocrine 24:217-21. 2004
  2. doi request reprint Where are we 10 years after the Women's Health Initiative?
    Roger A Lobo
    Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Columbia University Medical Center, 622 West 168th Street, New York, New York 10032, USA
    J Clin Endocrinol Metab 98:1771-80. 2013
  3. ncbi request reprint Different mechanisms for benefit and risk of coronary heart disease and stroke in early postmenopausal women: a hypothetical explanation
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University, New York, NY 10032, USA
    Menopause 18:237-40. 2011
  4. ncbi request reprint Appropriate use of hormones should alleviate concerns of cardiovascular and breast cancer risk
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Maturitas 51:98-109. 2005
  5. ncbi request reprint Potential options for preservation of fertility in women
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York 10032, USA
    N Engl J Med 353:64-73. 2005
  6. doi request reprint Evidence-based medicine and the management of menopause
    Rogerio Lobo
    Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York 10032, USA
    Clin Obstet Gynecol 51:534-8. 2008
  7. ncbi request reprint Choice of treatment for women with polycystic ovary syndrome
    Roger A Lobo
    Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Fertil Steril 86:S22-3. 2006
  8. ncbi request reprint Should symptomatic menopausal women be offered hormone therapy?
    Rogerio A Lobo
    Columbia University, Columbia University Medical Center, New York, NY, USA
    MedGenMed 8:1 p preceding 35. 2006
  9. ncbi request reprint Surgical menopause and cardiovascular risks
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY 10032, USA
    Menopause 14:562-6. 2007
  10. doi request reprint Metabolic syndrome after menopause and the role of hormones
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, United States
    Maturitas 60:10-8. 2008

Detail Information

Publications64

  1. ncbi request reprint The rationale for low-dose hormonal therapy
    Rogerio A Lobo
    Columbia University s College of Physicians and Surgeons, 622 West 168 Street, 16th Floor, New York, NY 10032, USA
    Endocrine 24:217-21. 2004
    ..A trend in hormonal therapy has been to use a lower dose. The justification for this approach based on both efficacy and safety is presented...
  2. doi request reprint Where are we 10 years after the Women's Health Initiative?
    Roger A Lobo
    Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Columbia University Medical Center, 622 West 168th Street, New York, New York 10032, USA
    J Clin Endocrinol Metab 98:1771-80. 2013
    ..Although it is appropriate to treat women with symptoms at the onset of menopause, because there is no proven therapy for primary prevention, in some women the use of HT for this role may at least be entertained...
  3. ncbi request reprint Different mechanisms for benefit and risk of coronary heart disease and stroke in early postmenopausal women: a hypothetical explanation
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University, New York, NY 10032, USA
    Menopause 18:237-40. 2011
    ..This notion is supported by data that estrogen regimens that decrease the risk of venous thrombosis (lower oral doses and transdermal therapy) may not be associated with an increase in ischemic stroke risk...
  4. ncbi request reprint Appropriate use of hormones should alleviate concerns of cardiovascular and breast cancer risk
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Maturitas 51:98-109. 2005
    ..Here data are presented showing efficacy with lower-doses and improved safety. With the use of lower-doses of estrogens, the progestogen dose, as required in women with a uterus, can be minimized...
  5. ncbi request reprint Potential options for preservation of fertility in women
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York 10032, USA
    N Engl J Med 353:64-73. 2005
  6. doi request reprint Evidence-based medicine and the management of menopause
    Rogerio Lobo
    Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York 10032, USA
    Clin Obstet Gynecol 51:534-8. 2008
    ..Understanding that there is a hierarchy of clinical data, the entire literature should be sought to provide the basis on which medicine is practiced...
  7. ncbi request reprint Choice of treatment for women with polycystic ovary syndrome
    Roger A Lobo
    Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Fertil Steril 86:S22-3. 2006
    ..However, for the majority of women, the metabolic disorder requires diligence in management, regardless of the presenting complaint...
  8. ncbi request reprint Should symptomatic menopausal women be offered hormone therapy?
    Rogerio A Lobo
    Columbia University, Columbia University Medical Center, New York, NY, USA
    MedGenMed 8:1 p preceding 35. 2006
    ....
  9. ncbi request reprint Surgical menopause and cardiovascular risks
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY 10032, USA
    Menopause 14:562-6. 2007
    ..To review the relevant literature on the effect of surgical menopause on cardiovascular disease (CVD)...
  10. doi request reprint Metabolic syndrome after menopause and the role of hormones
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, United States
    Maturitas 60:10-8. 2008
    ..The purpose of this review is to focus on the importance of metabolic syndrome (MBS) and its increased prevalence in postmenopausal (PM) women. Also the role of hormonal therapy in PM women with MBS will be discussed...
  11. doi request reprint Evidence-based approach to menopause. Foreword
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York, USA
    Clin Obstet Gynecol 51:533. 2008
  12. doi request reprint Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile
    Rogerio A Lobo
    Columbia University Medical Center, New York, New York
    Fertil Steril 92:1025-38. 2009
    ..To evaluate the effects of a tissue-selective estrogen complex (TSEC) composed of bazedoxifene/conjugated estrogens (BZA/CE) on menopausal symptoms, metabolic parameters, and overall safety...
  13. ncbi request reprint Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women: results from 2 large clinical trials
    Rogerio A Lobo
    Columbia University College of Physicians and Surgeons, 622 W 168th St, New York, NY 10032, USA
    Arch Intern Med 164:482-4. 2004
  14. ncbi request reprint Formulations and use of androgens in women
    Micheline C Chu
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, 622 W 168th St, PH 16 77, New York, NY 10032, USA
    Mayo Clin Proc 79:S3-7. 2004
    ..This review discusses the definition of androgen insufficiency, anticipated effects of androgen treatment on several factors of health, and treatment options for women with androgen insufficiency...
  15. ncbi request reprint What are the key features of importance in polycystic ovary syndrome?
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Fertil Steril 80:259-61. 2003
  16. ncbi request reprint The importance of diagnosing the polycystic ovary syndrome
    R A Lobo
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Ann Intern Med 132:989-93. 2000
    ..An opportunity exists for preventive therapy, which should improve the reproductive, metabolic, and cardiovascular risks...
  17. ncbi request reprint Early ovarian ageing: a hypothesis. What is early ovarian ageing?
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, PH 16 Room 28E, 622 West 168 Street, New York, NY 10032 3784, USA
    Hum Reprod 18:1762-4. 2003
    ..How will certain women with early ovarian ageing be identified, what hormonal and other factors should be measured, and what advice is reasonable for these young women?..
  18. ncbi request reprint Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism
    R A Lobo
    Department of Obstetrics and Gynecology, Columbia Presbyterian Medical Center, New York, New York 10032 3784, USA
    Fertil Steril 76:13-24. 2001
    ..To determine the effects of lower doses of conjugated equine estrogens (CEE) alone or CEE and medroxyprogesterone acetate (MPA) on lipoproteins, carbohydrate metabolism, and coagulation/fibrinolytic factors...
  19. ncbi request reprint Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University, College of Physicians and Surgeons and New York Presbyterian Hospital, New York, New York 10032, USA
    Fertil Steril 79:1341-52. 2003
    ..We sought to characterize the hormonal effects of the combination of oral esterified estrogens and methyltestosterone and to investigate whether this regimen improves hypoactive sexual desire...
  20. ncbi request reprint Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B
    Micheline C Chu
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Fertil Steril 84:1685-8. 2005
    ..To investigate Müllerian-inhibiting substance (MIS) levels in women with polycystic ovary syndrome (PCOS), as well as relationships to ovarian morphology, levels of inhibin B, and other reproductive hormones...
  21. ncbi request reprint Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin
    Micheline C Chu
    Department of Obstetrics and Gynecology, Columbia University, New York, NY, USA
    Am J Obstet Gynecol 194:100-4. 2006
    ....
  22. ncbi request reprint A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol
    Margery S Gass
    Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    Maturitas 49:140-7. 2004
    ..To assess the efficacy and safety of 17-beta estradiol buccal tablets in reducing hot flush frequency (HFF) in postmenopausal women...
  23. ncbi request reprint Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial
    Anne Z Steiner
    Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA
    Menopause 12:728-33. 2005
    ..To determine if 17beta-estradiol increases blood pressure in postmenopausal women...
  24. ncbi request reprint Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors
    Gary S Nakhuda
    Columbia University College of Physicians and Surgeons, Division of Reproductive Endocrinology and Infertility, Centre for Women s Reproductive Care, New York, NY 10019, USA
    Reprod Biomed Online 22:S88-93. 2011
    ..For oocyte donors, measurement of AMH appears most useful for determining gonadotrophin sensitivity in order to mitigate symptoms consistent with ovarian hyperstimulation...
  25. ncbi request reprint A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome
    Micheline C Chu
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Fertil Steril 86:1669-75. 2006
    ..To determine whether it would be preferable to prescribe oral or transdermal estrogen to symptomatic postmenopausal women with metabolic syndrome (MBS)...
  26. doi request reprint The complex relationship between hypothalamic amenorrhea and polycystic ovary syndrome
    Jeff G Wang
    Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Columbia University, New York, New York 10032, USA
    J Clin Endocrinol Metab 93:1394-7. 2008
    ..We explored the coexistence of these two disorders in women with HA/PCOM by analyzing their androgen response to gonadotropins and by following their clinical characteristics over time...
  27. ncbi request reprint Müllerian inhibiting substance is an accurate marker of ovarian response in women of advanced reproductive age undergoing IVF
    Gary S Nakhuda
    Columbia University College of Physicians and Surgeons, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, New York, NY 10025, USA
    Reprod Biomed Online 14:450-4. 2007
    ....
  28. doi request reprint Metabolic syndrome in postmenopausal women: the influence of oral or transdermal estradiol on inflammation and coagulation markers
    Micheline C Chu
    Department of Obstetrics, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Am J Obstet Gynecol 199:526.e1-7. 2008
    ..The objective of the study was to determine whether the route of administration of estrogen therapy in women with metabolic syndrome (MBS) influences inflammation and coagulation parameters...
  29. ncbi request reprint Elevated serum müllerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization
    Gary S Nakhuda
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Fertil Steril 85:1541-3. 2006
    ..62 +/- 0.87 vs. 0.63 +/- 0.09 ng/mL; P=.0036), indicating that MIS could potentially serve as a useful marker for identifying patients at risk for OHSS...
  30. ncbi request reprint Müllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome
    Jeff G Wang
    Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Am J Obstet Gynecol 196:77.e1-5. 2007
    ....
  31. doi request reprint Dehydroepiandrosterone in follicular fluid is produced locally, and levels correlate negatively with in vitro fertilization outcomes
    Liyun Li
    Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York 10032, USA
    Fertil Steril 95:1830-2. 2011
    ..Follicular fluid DHEA is produced in part within the ovary. Although follicular DHEA correlated with estradiol and testosterone, it correlated negatively with oocyte and embryo quality...
  32. ncbi request reprint The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study
    Jeff G Wang
    Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, College of Physicians and Surgeons, Columbia University, New York, New York 10023, USA
    Fertil Steril 88:240-3. 2007
    ..A larger trial is needed to confirm the findings of this pilot study and to evaluate the effect of cinnamon extract on menstrual cyclicity...
  33. ncbi request reprint Areas for future inquiry
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia Presbyterian Medical Center, Columbia University, 622 West 168th Street, PH 16, New York, NY 10032, USA
    Endocrinol Metab Clin North Am 33:761-9. 2004
    ..Osteoporosis, heart disease, and cancer remain worldwide challenges for women's health. This article discusses areas for future inquiry in these areas of research...
  34. ncbi request reprint Polycystic ovary syndrome after menopause: a case report
    Samuel Pauli
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    J Reprod Med 49:491-4. 2004
    ..Little is known about zhat happens to ovarian morphology or testosterone production in women with PCOS after menopause, and it is unclear how these women should be treated for the complaint of hirsutism...
  35. ncbi request reprint Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents
    Miriam E Silfen
    Department of Pediatrics, Division of Pediatric Endocrinology, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA
    J Clin Endocrinol Metab 88:4682-8. 2003
    ..Our data also suggest differences in the IGF system between nonobese and obese adolescents with PCOS...
  36. ncbi request reprint Unopposed estradiol therapy in postmenopausal women: results from two randomized trials
    Anne Z Steiner
    Department of Obstetrics and Gynecology, University of Southern California, Keck School of Medicine, Los Angeles, California 90033, USA
    Obstet Gynecol 109:581-7. 2007
    ..To estimate the rates of endometrial hyperplasia, bleeding episodes, and interventions among menopausal women receiving unopposed oral estradiol or placebo therapy with ultrasound monitoring over 3 years...
  37. ncbi request reprint Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause
    Wendy J Mack
    Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA
    Fertil Steril 82:391-7. 2004
    ..To compare common carotid artery intima-media thickness (IMT) between women who had natural menopause with those who had surgical menopause and to correlate IMT with time since menopause...
  38. doi request reprint Increasing adiposity in normal ovulatory women affects adipocytokine expression in subcutaneous and visceral abdominal fat
    Pratibhasri A Vardhana
    Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Columbia University Medical Center, New York, NY 10032, USA
    Int J Gynaecol Obstet 104:121-4. 2009
    ....
  39. pmc Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy
    Bo Yu
    Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York 10032, USA
    Cancer 116:2099-105. 2010
    ..The objective of the current study was to assess levels of mullerian inhibitory substance (MIS), estradiol (E2), follicle-stimulating hormone (FSH), and menstrual status, in women undergoing chemotherapy...
  40. doi request reprint Not all women diagnosed with PCOS share the same cardiovascular risk profiles
    Vuk P Jovanovic
    Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York 10032, USA
    Fertil Steril 94:826-32. 2010
    ..We conclude that not all women with PCOS should be considered as being similar in terms of cardiovascular risk profiles...
  41. pmc Should symptomatic menopausal women be offered hormone therapy?
    Rogerio A Lobo
    Columbia University, Columbia University Medical Center, New York, NY, USA
    MedGenMed 8:40. 2006
    ....
  42. ncbi request reprint Triplet pregnancy after ovulation induction with an aromatase inhibitor
    Cary L Dicken
    Department of Obstetrics and Gynecology, Center for Women s Reproductive Care, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Fertil Steril 90:1199.e9-11. 2008
    ..To describe the first reported case of a triplet pregnancy subsequent to the use of an aromatase inhibitor for ovulation induction...
  43. ncbi request reprint Views on recent trials and the future of hormonal therapy
    Rogerio A Lobo
    Department of Obstetrics and Gynecology, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA
    Clin Obstet Gynecol 47:424-7. 2004
  44. ncbi request reprint Menopausal Sexual Interest Questionnaire (MSIQ): a unidimensional scale for the assessment of sexual interest in postmenopausal women
    Raymond C Rosen
    Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
    J Sex Marital Ther 30:235-50. 2004
    ..The MSIQ demonstrated adequate construct validity, with all three domains showing a high degree of sensitivity and with two of the three exhibiting specificity to the effects of treatment...
  45. ncbi request reprint Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters
    Enrico Carmina
    Department of Clinical Medicine, University of Palermo, Palermo, Italy
    Fertil Steril 84:413-9. 2005
    ....
  46. ncbi request reprint Does ovarian blood flow distinguish between ovulatory and anovulatory patients with polycystic ovary syndrome?
    Enrico Carmina
    Department of Clinical Medicine, University of Palermo, Palermo, Italy
    Am J Obstet Gynecol 189:1283-6. 2003
    ..The purpose of this study was to determine whether parameters of ovarian blood flow distinguish between women with polycystic ovary syndrome (PCOS) who ovulate and those who are anovulatory...
  47. ncbi request reprint Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet
    Enrico Carmina
    Department of Clinical Medicine, University of Palermo, Italy
    Hum Reprod 18:2289-93. 2003
    ..The study aim was to determine differences in body mass in two populations of women (USA and Italy) with polycystic ovary syndrome (PCOS), and to assess the effect of diet on body mass and cardiovascular risk factors...
  48. doi request reprint Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial
    Gloria Bachmann
    Division of Obstetrics and Gynecology, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USA
    Obstet Gynecol 111:67-76. 2008
    ..To evaluate the efficacy of two vaginal doses of estradiol (E2) compared with placebo in the treatment of atrophic vaginitis...
  49. ncbi request reprint Perspectives on the Women's Health Initiative trial of hormone replacement therapy
    David A Grimes
    Family Health International, Research Triangle Park, North Carolina 27709, USA
    Obstet Gynecol 100:1344-53. 2002
    ..Heart disease prevention strategies of proven value include exercise, weight control, blood pressure and lipid control, and avoidance of smoking. Hormone replacement therapy should not be used for this purpose...
  50. ncbi request reprint Homocysteine in women's health
    Rogerio A Lobo
    Menopause 10:271-3. 2003
  51. ncbi request reprint Transdermal drug delivery: clinical considerations for the obstetrician-gynecologist
    Russell O Potts
    Russ Potts Consulting, LLC, San Francisco, California, USA
    Obstet Gynecol 105:953-61. 2005
    ..Created as an alternative route of administration to improve patient compliance as well as to reduce side effects, the transdermal delivery of drugs now represents a $1.5 to $2 billion market and is growing rapidly...
  52. ncbi request reprint Does metformin induce ovulation in normoandrogenic anovulatory women?
    Enrico Carmina
    Department of Clinical Medicine, University of Palermo, Palermo, Italy
    Am J Obstet Gynecol 191:1580-4. 2004
    ..This study was undertaken to evaluate the efficacy of metformin in women with anovulation who do not have evidence for hyperandrogenism and classic polycystic ovary syndrome...
  53. ncbi request reprint Endothelial dysfunction in PCOS: role of obesity and adipose hormones
    E Carmina
    Department of Clinical Medicine, University of Palermo, Italy
    Am J Med 119:356.e1-6. 2006
    ..This study was designed to determine if abnormal carotid intima-media thickness (IMT) and brachial flow-mediated dilation (FMD) in young women with PCOS may be explained by insulin resistance and elevated adipocytokines...
  54. ncbi request reprint The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition
    Frederick Naftolin
    Yale University, Department of Obstetrics, Gynecology and Reproductive Sciences, New Haven, Connecticut 06520 8063, USA
    Fertil Steril 81:1498-501. 2004
    ..Randomized controlled trials are urgently needed to test cardioprotection in women starting treatment during the menopausal transition...
  55. ncbi request reprint Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome
    Enrico Carmina
    Department of Clinical Medicine, University of Palermo, Palermo, Italy
    Fertil Steril 82:661-5. 2004
    ..To determine the prevalence of insulin resistance (IR) in women with polycystic ovary syndrome (PCOS) using baseline fasting blood measurements of glucose and insulin...
  56. ncbi request reprint Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial
    Wendy J Mack
    Department of Preventive Medicine, University of Southern California, Los Angeles, USA
    Atherosclerosis 168:91-8. 2003
    ..To determine whether the estrogen-related reduction in atherosclerosis progression demonstrated in the estrogen in the prevention of atherosclerosis trial (EPAT) is modified by body mass index (BMI)...
  57. pmc Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women
    Roksana Karim
    Department of Pediatrics, Keck School of Medicine, University of Southern California, 1540 Alcazar Street, CHP Suite 222R, Los Angeles, California 90033, USA
    J Clin Endocrinol Metab 93:131-8. 2008
    ..Postmenopausal hormone therapy has been examined extensively in relation to cardiovascular disease. However, research relating serum levels of sex hormones to cardiovascular disease is sparse, and the results are inconclusive...
  58. ncbi request reprint Practical recommendations for hormone replacement therapy in the peri- and postmenopause
    Henry Burger
    Climacteric 7:210-6. 2004
  59. ncbi request reprint A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women
    Enrico Carmina
    Department of Endocrinology, University of Palermo, Palermo, Italy
    Clin Endocrinol (Oxf) 57:231-4. 2002
    ..To compare the relative effectiveness of two newer antiandrogens (flutamide and finasteride) with cyproterone acetate (CPA), at both low and high doses in the treatment of moderate to severe acne in hyperandrogenic women...
  60. pmc Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society
    Wulf H Utian
    Menopause 15:584-602. 2008
    ....
  61. ncbi request reprint Treatment of hyperandrogenic alopecia in women
    Enrico Carmina
    Department of Obstetrics and Gynecology, University of Palermo, Palermo, Italy
    Fertil Steril 79:91-5. 2003
    ..To determine the effectiveness of various antiandrogens for the treatment of premenopausal women with hyperandrogenic alopecia...
  62. ncbi request reprint Effect of finasteride on the ovulatory function of normal women
    I Lane Wong
    Fertil Steril 79:1455-7. 2003
  63. doi request reprint Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline
    Kathryn A Martin
    Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Clin Endocrinol Metab 93:1105-20. 2008
    ..Our objective was to develop clinical practice guidelines for the evaluation and treatment of hirsutism in premenopausal women...
  64. ncbi request reprint Toward optimal health: the experts discuss polycystic ovary syndrome
    Andrea Dunaif
    J Womens Health Gend Based Med 11:579-84. 2002